We have previously shown that TLR2 might mediate the neurotoxic and pro-inflammatory effects of α-synuclein oligomers [8] and it has been recently reported that levels of TLR2 expression are increased in the brains of patients with synucleinopathy [11–13]. Here, TLR2 is linked to synucleinopathy.